Finance

Beta
Ask
Lists
BALAXI:NSE
Balaxi Pharmaceuticals Ltd
₹ २३.१०
-०.६०%
(-०.१४) 1D
जुन १२, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BALAXI...
Open
₹ २३.७०
High
₹ २३.७०
Low
₹ २२.५०
Mkt. cap
१.२६ अरब
Avg. vol.
३५.३२ हजार
Volume
३४.०६ हजार
P/E ratio
८८.८५
52-wk high
₹ ५५.६४
52-wk low
₹ १५.२०
EPS
₹ ०.२६
No. of employees
६००
Open
₹ २३.७०
High
₹ २३.७०
Low
₹ २२.५०
Mkt. cap
१.२६ अरब
Avg. vol.
३५.३२ हजार
Volume
३४.०६ हजार
P/E ratio
८८.८५
52-wk high
₹ ५५.६४
52-wk low
₹ १५.२०
EPS
₹ ०.२६
No. of employees
६००
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
६ घण्टा पहिले
When the AI Trade Collapses, These 3 S&P 500 Sectors Are Your Best Bet
Bloomberg.com
Bloomberg.com
·
८ घण्टा पहिले
Equity Funding Squeeze Driven By AI Rally, SpaceX IPO Stretches Banks
Investor's Business Daily
Investor's Business Daily
·
१७ मिनेट पहिले
Futures Rise, Oil Dives As Trump Announces Iran Deal
TheStreet
TheStreet
·
४ घण्टा पहिले
Why Rocket Lab stock tumbled on Nasdaq-100 news
About Balaxi Pharmaceuticals Ltd
CEO-
Employees६००
Founded१९४२
Headquarters-
Sector-
Websitebalaxipharma.in
Last report
२०२६ मे २८
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
७०.७१ करोड / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
७०.७४ करोड
५६.१८ करोड
७२.५४ करोड
७०.७१ करोड
Cost of goods sold
३९.५६ करोड
२९.०३ करोड
४१.७४ करोड
४०.५५ करोड
Cost of revenue
३९.५६ करोड
२९.०३ करोड
४१.७४ करोड
४०.५५ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२७.०३ करोड
२५.९८ करोड
२७.७२ करोड
३०.०४ करोड
Operating expense
२७.५० करोड
२६.४६ करोड
२८.२८ करोड
३०.६९ करोड
Total operating expenses
६७.०६ करोड
५५.४९ करोड
७०.०१ करोड
७१.२४ करोड
Operating income
३.६९ करोड
६८.४१ लाख
२.५३ करोड
-५२.४८ लाख
Other non operating income
-१.७८ करोड
१.५८ करोड
९.५७ लाख
२.९२ करोड
EBT including unusual items
९०.३४ लाख
१.३८ करोड
१.६१ करोड
१.४० करोड
EBT excluding unusual items
९०.३४ लाख
१.३८ करोड
१.६१ करोड
१.४० करोड
Income tax expense
६१.३३ लाख
१.१७ करोड
१.३० करोड
७८.९७ लाख
Effective tax rate
६७.८९%
८४.८२%
८१.०५%
५६.३१%
Other operating expenses
-
-
-
-
Net income
२९.०१ लाख
२०.९० लाख
३०.५० लाख
६१.२८ लाख
Net profit margin
०.४१%
०.३७%
०.४२%
०.८७%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-१.०१ करोड
-८९.२२ लाख
-१.०२ करोड
-९८.९९ लाख
Net interest expenses
-१.०१ करोड
-८९.२२ लाख
-१.०२ करोड
-९८.९९ लाख
Depreciation and amortization charges
४६.२५ लाख
४८.४५ लाख
५५.९५ लाख
६४.६५ लाख
EBITDA
४.११ करोड
१.१६ करोड
२.९६ करोड
१.३४ लाख
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer